NCT02819908View on ClinicalTrials.gov

Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Intraocular Lens Associated Postoperative Inflammation
Interventions
DRUG

Imprimis Dropless

Tri-Moxi-Vanc transzonular intravitreal injection

DRUG

Imprimis Less Drops

Pred-Moxi-Ketorolac and Pred-Ketorolac topical instillation qd postoperatively

Trial Locations (1)

32409

Eye Center of North Florida, Panama City

All Listed Sponsors
lead

Eye Center of North Florida

OTHER

NCT02819908 - Dropless™ vs. Less Drops™ Pharmaceutical Regimens After Cataract Surgery | Biotech Hunter | Biotech Hunter